Sign In
Buy BV
$12.02
+0.0200 (+0.167%)
At Close: Jun 03, 2026
BrightView Holdings, Inc. Announces Fourth Quarter and Fiscal Year 2025 Earnings Release Date, Conference Call and Webcast
04:15pm, Thursday, 30'th Oct 2025
BLUE BELL, Pa.--(BUSINESS WIRE)--BrightView Holdings, Inc. (NYSE: BV) will release its earnings results for the fourth quarter and fiscal year 2025 after the market closes on Wednesday, November 19, 2
BrightView Unites 19,000 Team Members with Pink Hats for Breast Cancer Awareness Month
06:15am, Wednesday, 01'st Oct 2025
BLUE BELL, Pa.--(BUSINESS WIRE)--BrightView (NYSE: BV), the nation's leading commercial landscaping company, is once again rallying its 19,000 team members nationwide in support of Breast Cancer Aware
BrightView Declares Seventh Consecutive Cash Dividend Payment on Preferred Stock
04:15pm, Thursday, 11'th Sep 2025
BLUE BELL, Pa.--(BUSINESS WIRE)--BrightView Holdings, Inc. (NYSE: BV), the leading commercial landscaping services company in the United States, announced today that the Company's Board of Directors h
BrightView Holdings, Inc. (BV) Q3 2025 Earnings Call Transcript
09:50am, Friday, 08'th Aug 2025
BrightView Holdings, Inc. (NYSE:BV ) Q3 2025 Earnings Call August 7, 2025 8:30 AM ET Company Participants Brett Urban - Executive VP, CFO & Principal Accounting Officer Chris Stoczko - Vice President
BrightView (BV) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
09:01pm, Wednesday, 06'th Aug 2025
The headline numbers for BrightView (BV) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimate
BrightView Holdings (BV) Lags Q3 Earnings and Revenue Estimates
08:11pm, Wednesday, 06'th Aug 2025
BrightView Holdings (BV) came out with quarterly earnings of $0.3 per share, missing the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.32 per share a year ago.
BrightView Holdings (BV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:01am, Wednesday, 30'th Jul 2025
BrightView (BV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
From Racetrack to Ballpark: BrightView Builds MLB Field at Bristol
06:30am, Tuesday, 29'th Jul 2025
BLUE BELL, Pa.--(BUSINESS WIRE)--Major League Baseball has made a name for itself creating unforgettable venues for its most iconic games—from a cornfield in Iowa to the historic Rickwood Field and
5 Stocks Brokers Adore Even as Economic Uncertainty Lingers
09:45am, Thursday, 17'th Jul 2025
Broker-backed picks like BTSG, GXO, BV, BLMN and ADM stand out as volatility rises and market uncertainty clouds rate cut timing.
BrightView Holdings, Inc. Announces Third Quarter Fiscal Year 2025 Earnings Release Date, Conference Call and Webcast
04:15pm, Wednesday, 16'th Jul 2025
BLUE BELL, Pa.--(BUSINESS WIRE)--BrightView Holdings, Inc. (NYSE: BV) will release its earnings results for the third quarter fiscal year 2025 after the market closes on Wednesday, August 6, 2025. Bri
Centene, BrightView Holdings, ArriVent BioPharma And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
08:22am, Wednesday, 02'nd Jul 2025
U.S. stock futures were higher this morning, with the Dow futures gaining around 0.2% on Wednesday.
BrightView Updates Fiscal 2025 Financial Guidance
04:15pm, Tuesday, 01'st Jul 2025
BLUE BELL, Pa.--(BUSINESS WIRE)--BrightView Holdings, Inc. (NYSE: BV) (the “Company” or “BrightView”), the leading commercial landscaping services company in the United States, today updated i
BrightView Declares Cash Dividend Payment on Preferred Stock
04:15pm, Thursday, 12'th Jun 2025
BLUE BELL, Pa.--(BUSINESS WIRE)--BrightView Holdings, Inc. (NYSE: BV), the leading commercial landscaping services company in the United States, announced today that the Company's Board of Directors h
Notable Data on Evofem's SOLOSEC in Recurrent Bacterial Vaginosis (BV) Released at ACOG Annual Meeting
08:14am, Wednesday, 11'th Jun 2025
-- BV Market Projected to Reach $1.0 Billion in the U.S. by 2033 -- -- BV Affects 21 Million U.S. Women; As many as 50% Experience Recurrent BV Within Six Months of Treatment -- SAN DIEGO , June 11, 2
BrightView Announces Pricing of Upsized Secondary Offering
06:45am, Thursday, 05'th Jun 2025
BLUE BELL, Pa.--(BUSINESS WIRE)--BrightView Holdings, Inc. (NYSE: BV) (“BrightView”) today announced the pricing of an underwritten secondary offering by a selling stockholder affiliated with KKR
